Pennsylvania Doctor Sentenced to State Prison for Reckless Controlled Substance Prescribing
Last updated 2026-09-18 · Source: attorneygeneral.gov
Primary source: attorneygeneral.gov: Pennsylvania Doctor Sentenced to State Prison for Reckless Controlled Substance Prescribing
A Wyoming County, Pennsylvania physician was sentenced to 14 to 48 months in state prison after pleading guilty to unlawfully prescribing Schedule II controlled substances. The investigation found the doctor failed to assess abuse or overdose risk, lacked supporting patient documentation, and did not monitor patient responses to medications. The case, brought by the Pennsylvania Attorney General's Office, signals active state-level criminal enforcement against prescribing practices that fall below accepted standards of care.
What this means for your practice
This sentencing is a direct warning to any prescriber operating in Pennsylvania — including those prescribing via telehealth platforms — that inadequate clinical documentation, failure to assess abuse or diversion risk, and lack of patient monitoring can result in criminal prosecution and state prison time, not just civil sanctions or license revocation. For telehealth brands, medspas, and any practice prescribing controlled substances, this case underscores three non-negotiable compliance pillars: (1) every controlled substance prescription must be supported by documented clinical justification in the patient's medical record; (2) risk of abuse, diversion, and overdose must be affirmatively assessed and documented before and throughout a course of treatment; and (3) patient response to medications must be actively monitored and recorded. The fact that the Pennsylvania Attorney General used a statewide investigating grand jury to pursue this case demonstrates that state prosecutors — not just the DEA or federal DOJ — are willing to invest significant investigative resources in controlled substance prescribing enforcement. Operators should audit their prescribing workflows, clinical documentation standards, and monitoring protocols now, before an investigation begins.
Pennsylvania AG Secures State Prison Sentence Against Wyoming County Doctor for Unlawful Controlled Substance Prescribing
The Pennsylvania Office of Attorney General announced that Dr. Raphael Benjamin Kon, 62, of Noxen, Pennsylvania, has been sentenced to 14 to 48 months in state prison following his guilty plea to unlawful administration, dispensing, delivery, gift, or prescription of a Schedule II controlled substance. Attorney General Dave Sunday made the announcement.
What Happened
An investigation — originating from a presentment by the 52nd Statewide Investigating Grand Jury — revealed a pattern of prescribing conduct that prosecutors characterized as reckless and dangerous to patients. Specifically, the investigation found that Dr. Kon:
- Failed to assess the enhanced risk of abuse, diversion, or overdose in relation to any medical benefit when continuously prescribing controlled substances to patients
- Lacked adequate documentation in patient medical files to support his prescribing decisions
- Did not monitor how patients were responding to the medications he prescribed
Following a 2024 search warrant executed at his medical office, Dr. Kon closed his practice and surrendered his DEA license. In August (year not specified in the source), he pleaded guilty to the charge before receiving his prison sentence.
Attorney General's Statement
> *"Patients trust their doctors to protect their health and safety, and this defendant broke that trust by recklessly prescribing potent medications. This type of behavior by a medical professional contributes to an addiction epidemic that already impacts every Pennsylvania community."* > — Attorney General Dave Sunday
The case was prosecuted by Deputy Attorney General Christy Schlottman.
Why This Case Matters to Healthcare Operators
This enforcement action is not an isolated anomaly — it reflects a broader pattern of state attorneys general taking an active role in controlled substance prescribing enforcement, working alongside or independently of federal agencies like the DEA.
For healthcare businesses prescribing controlled substances — whether through in-person clinics, telehealth platforms, medspas, or multi-state practices — this case illuminates the three documentation and clinical oversight failures that prosecutors view as criminal conduct:
#### 1. Failure to Assess Risk Before and During Prescribing
The investigation found that Dr. Kon did not assess the "enhanced risk of abuse, diversion or overdose with any medical benefit" during a continuous course of prescribing. This is a foundational element of any legitimate controlled substance treatment plan. Risk assessment tools, patient history reviews, and documented clinical reasoning are not optional — they are the evidentiary record that separates legitimate prescribing from criminal conduct.
#### 2. No Supporting Documentation in Patient Files
Prescribing that is "not supported by documentation in patient medical files" is a recurring theme in both state and federal enforcement actions. Every prescription for a controlled substance should be traceable to a documented clinical encounter, a diagnosis, a treatment rationale, and an ongoing care plan. Gaps in documentation — especially in telehealth encounters where there is no in-person examination — are a significant enforcement risk.
#### 3. No Monitoring of Patient Response
Prescribing without monitoring how patients respond to their medications is both a clinical failure and, as this case demonstrates, a legal one. Active monitoring — documented in the record — demonstrates that the prescriber is engaged in genuine therapeutic management rather than rote prescription issuance.
The Role of the Statewide Investigating Grand Jury
The use of the 52nd Statewide Investigating Grand Jury in this case is significant. Grand jury investigations allow prosecutors to compel testimony and documents, examine prescribing patterns across a practice, and build detailed criminal cases before charges are ever filed. Healthcare operators should understand that state-level investigations into prescribing conduct can be thorough, lengthy, and concluded with criminal — not merely regulatory — outcomes.
Key Compliance Takeaways for Prescribing Practices
- Document every prescribing decision with clinical justification tied to the patient's diagnosis and treatment plan
- Conduct and record risk assessments for abuse, diversion, and overdose at initiation and throughout any course of controlled substance treatment
- Implement a monitoring protocol and document patient follow-up, including response to medication, adherence, and any red flags
- Train all prescribers — including those operating via telehealth — on the documentation standards required for controlled substance prescribing
- Conduct internal audits of controlled substance prescribing patterns to identify gaps before regulators or prosecutors do
This case is a reminder that the consequences of inadequate prescribing practices extend well beyond civil penalties or license sanctions — they can result in state criminal prosecution and incarceration.
Key Facts
| Detail | Value | |---|---| | Defendant | Dr. Raphael Benjamin Kon, 62, of Noxen, Pennsylvania | | Sentence | 14 to 48 months in state prison | | Charge | Guilty plea to unlawful administration, dispensing, delivery, gift, or prescription of a Schedule II controlled substance | | Investigating Body | 52nd Statewide Investigating Grand Jury | | Key Failures Found | No abuse/diversion/overdose risk assessment; no supporting patient documentation; no patient monitoring | | Additional Consequence | Kon closed his office and surrendered his DEA license following a 2024 search warrant |
Frequently Asked Questions
What specific conduct led to this doctor's criminal conviction?
The investigation found three core failures: Dr. Kon did not assess the enhanced risk of abuse, diversion, or overdose when prescribing controlled substances; his prescribing was not supported by documentation in patient medical files; and he did not monitor how patients were responding to their medications.
Was this a federal or state prosecution?
This was a state-level criminal prosecution brought by the Pennsylvania Office of Attorney General, not a federal DEA or DOJ action. The case originated from a presentment by the 52nd Statewide Investigating Grand Jury.
What happened to the doctor's DEA license and practice?
Following a 2024 search warrant at his medical office, Dr. Kon closed his practice and surrendered his DEA license, in addition to receiving his state prison sentence.
What does this mean for telehealth or multi-state prescribing operations?
It means that state attorneys general — not just federal agencies — are actively prosecuting controlled substance prescribing violations. Any practice prescribing controlled substances must maintain thorough documentation, conduct risk assessments, and monitor patients, regardless of whether care is delivered in person or via telehealth.
What can my practice do to reduce exposure to this type of enforcement action?
Based on the failures identified in this case, practices should ensure every controlled substance prescription is supported by clinical documentation in the patient's file, that risk of abuse and diversion is assessed and recorded, and that patient response to medications is actively monitored and documented throughout treatment.